2017 American Transplant Congress

Saturday, April 29, 2017

5:30pm-7:30pm

Serum AFP Greater Than 200 ng/ml as a Predictor for Low Survival in Patients with Hepatocelullar Carcinoma Recurrence in a Brazilian Multicentric Study.

I. Boin,¹ M. Possatto,¹ E. Ataide,¹ R. Silva,² R. Silva,² H. Felicio,² L. Amado,³ A. Lima,³ T. Seva-Pereira.¹

Poster Session A: Clinical Science: Liver - Hepatocellular Carcinoma and Cholangiocarcinoma Malignancies  •  Hall D1

5:30pm-7:30pm

Sexual Acquisition of HIV-Infection After Kidney Transplantation: Late Presentation and Potentially Fatal Complications.

M. Cristelli, M. Ribeiro, D. Santos, M. Mazolin, H. Tedesco-Silva, J. Medina-Pestana.

Poster Session A: Kidney Complications I  •  Hall D1

5:30pm-7:30pm

Short- and Long-Term Graft Survival After Kidney Transplantation in Western Europe.

M. Coemans,¹ G. Verbeke, D. Anglicheau, O. Bestard, M. Giral, M. Naesens.^1,2

Poster Session A: Deceased Donor Issues I: Allocation, KDPI and Recipient Selection  •  Hall D1

5:30pm-7:30pm

Short-Term Combination Treatment of FK506 and Anti-CD40 Ligand Remarkably Prolong Allograft Survival Time in Mouse Skin Transplantation.

X. Zhang, Z. Ding, M. Yang, Y. Miao, Y. Yang, P. Zhou.

Poster Session A: Immunosuppression  •  Hall D1

5:30pm-7:30pm

Single Nuclear Polymorphisms of Complement Component 4 and Component 5 in Renal Transplant Recipients with Antibody-Mediated Rejection.

Z. Wang, Z. Han, J. Tao, R. Tan, M. Gu.

Poster Session A: Antibody Mediated Rejection in Kidney Transplant Recipients I  •  Hall D1

5:30pm-7:30pm

Single-Center Initial Experience in Treating Chronic Hepatitis C in Kidney Transplant Recipients.

G. Meinerz, C. da Silva, R. Bruno, E. Keitel, V. Garcia.

Poster Session A: Viral Conundrums  •  Hall D1

5:30pm-7:30pm

Solid Organ Cancer After Kidney Transplantation: Risk Factors and Long Term Impact.

A. Buxeda, D. Redondo, M. Pérez-Sáez, A. Bartolomé, M. Mir, A. Pascual, A. Sans, M. Crespo, J. Pascual.

Poster Session A: Kidney Complications I  •  Hall D1

5:30pm-7:30pm

Steatotic Human Livers Show Inferior Function Compared to Non-Steatotic Livers During Ex-Situ Viability Assessment by Oxygenated Machine Perfusion.

N. Karimian,¹ V. Huang,¹ F. Fontan,¹ M. Aburawi,¹ S. Geerts,¹ S. Mert,¹ I. Beijert,² R. Porte,² M. Yarmush,¹ K. Uygun,¹ J. Markmann,¹ H. Yeh.¹

Poster Session A: Ischemic Injury and Organ Preservation Session I  •  Hall D1

5:30pm-7:30pm

Steroid Withdrawal and De Novo Donor-Specific HLA Antibodies in Renal Transplant Patients: A Prospective, Randomized, Controlled Study in Parallel Groups. Preliminary Results.

J. Alonso-Titos,¹ P. Ruiz-Esteban,¹ E. Palma,¹ V. Lopez,¹ A. Caballero,² M. Leon,³ M. Cobos,⁴ J. Cruzado,⁵ J. Sellares,⁶ A. Torres,⁴ D. Hernandez.¹

Poster Session A: Antibody Mediated Rejection in Kidney Transplant Recipients I  •  Hall D1

5:30pm-7:30pm

Subclinical Rejections in Kidney Transplant Recipients Treated with Direct Acting Antiviral Agents for Hepatitis C Treatment within 1 Year of Transplant.

T. Rege,¹ K. Hatahet,¹ A. Gillespie,¹ M. Ghanta,¹ I. Lee,¹ K. Qureshi,¹ K. Lau,² S. Karhadkar,² A. DiCarlo,² S. Constantinescu,¹ S. Rao.¹

Poster Session A: Kidney Complications I  •  Hall D1